| Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer J Tintelnot, Y Xu, TR Lesker, M Schönlein, L Konczalla, AD Giannou, ... Nature 615 (7950), 168-174, 2023 | 104 | 2023 |
| Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches J Tintelnot, A Stein World journal of gastroenterology 25 (29), 3920, 2019 | 60 | 2019 |
| Efficacy of ipilimumab vs FOLFOX in combination with nivolumab and trastuzumab in patients with previously untreated ERBB2-positive esophagogastric adenocarcinoma: the AIO … A Stein, L Paschold, J Tintelnot, E Goekkurt, SS Henkes, D Simnica, ... JAMA oncology 8 (8), 1150-1158, 2022 | 38 | 2022 |
| Arc/Arg3. 1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activation F Ufer, P Vargas, JB Engler, J Tintelnot, B Schattling, H Winkler, S Bauer, ... Science immunology 1 (3), eaaf8665-eaaf8665, 2016 | 36 | 2016 |
| PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer A Stein, D Simnica, C Schultheiß, R Scholz, J Tintelnot, E Gökkurt, ... Journal for ImmunoTherapy of Cancer 9 (7), 2021 | 35 | 2021 |
| Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma-the randomized phase 2 … J Tintelnot, E Goekkurt, M Binder, P Thuss-Patience, S Lorenzen, ... BMC cancer 20, 1-10, 2020 | 34 | 2020 |
| Nanobody targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies J Tintelnot, N Baum, C Schultheiß, F Braig, M Trentmann, J Finter, ... Molecular Cancer Therapeutics 18 (4), 823-833, 2019 | 28 | 2019 |
| LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma … A Stein, L Paschold, J Tintelnot, E Goekkurt, PC Thuss-Patience, ... Annals of Oncology 32, S1331, 2021 | 20 | 2021 |
| Translational analysis and final efficacy of the AVETUX trial–Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer J Tintelnot, I Ristow, M Sauer, D Simnica, C Schultheiß, R Scholz, ... Frontiers in Oncology 12, 993611, 2022 | 13 | 2022 |
| Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma C Nitschke, B Markmann, P Walter, A Badbaran, M Tölle, J Kropidlowski, ... Clinical chemistry 69 (3), 295-307, 2023 | 8 | 2023 |
| Arc/Arg3. 1 defines dendritic cells and Langerhans cells with superior migratory ability independent of phenotype and ontogeny in mice J Tintelnot, F Ufer, JB Engler, H Winkler, K Lücke, HW Mittrücker, ... European Journal of Immunology 49 (5), 724-736, 2019 | 8 | 2019 |
| Calcium channel β3 subunit regulates ATP-dependent migration of dendritic cells MS Woo, F Ufer, JK Sonner, A Belkacemi, J Tintelnot, PJ Sáez, PF Krieg, ... Science Advances 9 (38), eadh1653, 2023 | 3 | 2023 |
| A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer M Moehler, M Michel, A Stein, J Trojan, J Marquardt, J Tintelnot, ... Future Oncology 17 (25), 3309-3319, 2021 | 3 | 2021 |
| Diet and immune response: how today’s plate shapes tomorrow’s health F Siracusa, J Tintelnot, F Cortesi, N Gagliani Trends in Immunology, 2023 | 2 | 2023 |
| First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial L Paschold, A Stein, B Thiele, J Tintelnot, SS Henkes, C Coith, ... Journal for Immunotherapy of Cancer 11 (6), 2023 | 2 | 2023 |
| UKE Paper of the Month October 2016 F Ufer, P Vargas, JB Engler, J Tintelnot, B Schattling, H Winkler, S Bauer, ... Science, 2016 | 2 | 2016 |
| Efficacy and quality of life for FOLFOX/bevacizumab+/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial HJ Schmoll, J Mann, F Meinert, B Garlipp, K Borchert, A Vogel, E Goekkurt, ... British Journal of Cancer 130 (2), 233-241, 2024 | 1 | 2024 |
| CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis T Zhang, R Wahib, DE Zazara, J Lücke, AM Shiri, J Kempski, L Zhao, ... OncoImmunology 12 (1), 2269634, 2023 | 1 | 2023 |
| Circulating tumor-macrophage fusion cells as stage independent, unfavourable, prognostic markers in pancreatic ductal adenocarcinoma C Nitschke, B Markmann, L Konczalla, J Kropidlowski, Y Belloum, ... European Journal of Surgical Oncology 48 (2), e131-e132, 2022 | 1 | 2022 |
| Roles of microbiota in pancreatic cancer development and treatment MS Cruz, J Tintelnot, N Gagliani Gut Microbes 16 (1), 2320280, 2024 | | 2024 |
